1. Expression of metalloproteinases 2 and 9 and plasma zinc concentrations in women with fibroadenoma
- Author
-
Ana Raquel Soares de Oliveira, Jennifer Beatriz Silva Morais, Carla Solange de Melo Escórcio Dourado, Benedito Borges da Silva, Antonio Gomes da Silva Neto, Igor Sabino Barros, Emanuelle de Sousa Ferreira, Luana Mota Martins, Dilina do Nascimento Marreiro, and Victor Alves de Oliveira
- Subjects
medicine.medical_specialty ,Medicine (General) ,Waist ,medicine.drug_class ,Matrix metalloproteinase ,Monoclonal antibody ,Matrix (chemical analysis) ,Mice ,R5-920 ,Internal medicine ,medicine ,Animals ,Humans ,Plasma zinc ,Chemistry ,General Medicine ,medicine.disease ,Fibroadenoma ,Matrix Metalloproteinases ,Zinc ,Endocrinology ,Cross-Sectional Studies ,Matrix Metalloproteinase 9 ,Immunohistochemistry ,Matrix Metalloproteinase 2 ,Body mass index - Abstract
SUMMARY OBJECTIVE: This study aims to investigate the association between the immunohistochemical expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and plasma zinc in women with fibroadenoma. METHODS: This cross-sectional study included 37 premenopausal women with fibroadenoma. Waist circumference and body mass index of the participants were measured. Plasma zinc concentrations were determined using atomic flame absorption spectrophotometry. Fragments of breast tissue were fixed and incubated with primary mouse monoclonal antibodies (monoclonal antibodies matrix metalloproteinase -2 -507 and monoclonal antibodies matrix metalloproteinase -9-439). Semi-quantitative analysis of matrix metalloproteinase-2 and matrix metalloproteinase-9 immunoreactivity was performed. Spearman’s test and Friedman’s test were used for statistical analyses. The p
- Published
- 2021